API SUPPLIERS

API Suppliers

70

US DMFs Filed

32

CEP/COS Certifications

JDMFs Filed

Other Certificates

Other Suppliers

API REF. PRICE (USD / KG)

6,417

API Market Place

13

INTERMEDIATES

2

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS

82

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

27

USFDA Exclusivities

1

DIGITAL CONTENT

Blog #PharmaFlow

0

News

47

REF STANDARD

EDQM

1

USP

1

JP

0

Other Listed Suppliers

1

SERVICES

0

Reset Filter

Product Main Page

Ask Us

Full Screen View

Finished Dosage Formulations

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

PHARMACEUTICAL RAW MATERIAL MOMETASONE F UROATE USP

Supporting Information : Click here to upload a PDF

Quantity (GMS)

100

Unit Rate (INR)

90

Unit Rate (INR)

99

Date

30-Sep-2016

Total Value (INR)

9,000

Total Value (INR)

9,900

Indian Port

Raxaul

HS Code

30033900

Bill Number

1384308

Finished Dosage Formulations

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

PHARMACEUTICAL RAW MATERIAL.MOMETASONE FURAOATE USP

Supporting Information : Click here to upload a PDF

Quantity (KGS)

2

Unit Rate (INR)

75,000

Unit Rate (INR)

75,160

Date

26-May-2016

Total Value (INR)

150,000

Total Value (INR)

150,319.9

Indian Port

Raxaul (INRXLB)

HS Code

30033900

Bill Number

7879025

Finished Dosage Formulations

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

PHARMACEUTICAL RAW MATERIAL.MOMETASONE FEROATE USP

Supporting Information : Click here to upload a PDF

Quantity (KGS)

1

Unit Rate (INR)

115,000

Unit Rate (INR)

115,250

Date

03-May-2016

Total Value (INR)

115,000

Total Value (INR)

115,250

Indian Port

Raxaul (INRXLB)

HS Code

30033900

Bill Number

7430252

Finished Dosage Formulations

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

PHARMACEUTICAL RAW MATERIAL.MOMETASONE FUROATE ESP

Supporting Information : Click here to upload a PDF

Quantity (KGS)

1

Unit Rate (INR)

89,000

Unit Rate (INR)

89,000

Date

31-Mar-2016

Total Value (INR)

89,000

Total Value (INR)

89,000

Indian Port

Raxaul

HS Code

30033900

Bill Number

6794987

Finished Dosage Formulations

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

PHARMACEUTICAL PRODUCTS=TROSONE-(MOMETASONE OINTMENT BP 0.1% W/W)-COMPOSITI...

Supporting Information : Click here to upload a PDF

Quantity (GMS)

10,000

Unit Rate (USD)

0.5

Unit Rate (INR)

0

Date

04-Jan-2016

Total Value (USD)

5,200

Total Value (INR)

0

Indian Port

JNPT

HS Code

30049099

Bill Number

2735972

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Dosage Form (FDF) export of 04201GDN4R obtained from Indian Custom Trade Statistics

04201GDN4R

04201GDN4R

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

70 API Suppliers

32 USDMF

25 CEP/COS

9 JDMF

8 EU WC

7 KDMF

28 NDC API

41 Listed Suppliers

DEVELOPMENTS

47 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Formulations

282 Dossiers

37 FDA Orange Book

119 Europe

17 Canada

59 Australia

25 South Africa

25 Listed Dossiers

DRUG PRODUCT COMPOSITION

OINTMENT;TOPICAL - 0.1%

CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.05MG/INH

AEROSOL, METERED;INHALATION - 0.10MG/INH

AEROSOL, METERED;INHALATION - 0.20MG/INH

SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

POWDER;INHALATION - 0.11MG/INH

POWDER;INHALATION - 0.22MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

Suppliers

10 Kerry

9 Roquette

8 Sigachi Industries

7 Gangwal Chemicals

6 Actylis

6 Microlex e.U

6 Seppic

5 Gangwal Healthcare

4 BASF

4 Nanjing Well Pharmaceutical

3 DFE Pharma

2 Finar

1 The Dow Chemical Company

1 Ideal Cures Pvt Ltd

1 Pharmatrans-Sanaq

1 Jai Radhe Sales

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Nanjing Bold Chemical

1 Vasa Pharmachem

1 Rochem International Inc

1 Kima Chemical

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Prachin Chemical

1 SPI Pharma

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders

19 Solubilizers

14 Thickeners and Stabilizers

14 Direct Compression

10 Parenteral

8 Coating Systems & Additives

8 Co-Processed Excipients

8 Film Formers & Plasticizers

CREAM;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - 0.05MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons